Gotcha. Re:your second paragraph, what you say reminds me of another ugly obstacle that Ocata and other biotechs must face in to achieve success, namely Big Pharma and their obvious determination to try to snuff out any company and/or technology which could impinge on their already filthy profits unless of course the company in question "plays ball" with them if you catch my drift. Couple that with the fact that these companies in Big Pharma are connected to lets just say VIPS with big clout in agencies and some influential legislators who for a price/special favors are in a position to at the very least delay things, and you get a somewhat less than rosy picture moving forward for any upstart company including ocata.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.